| Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential E Monzani, F Facchetti, E Galmozzi, E Corsini, A Benetti, C Cavazzin, ... European journal of cancer 43 (5), 935-946, 2007 | 585 | 2007 |
| Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype A Salmaggi, A Boiardi, M Gelati, A Russo, C Calatozzolo, E Ciusani, ... Glia 54 (8), 850-860, 2006 | 303 | 2006 |
| Molecular mechanisms triggered by mercury GP Guzzi, CAM La Porta Toxicology 244 (1), 1-12, 2008 | 273 | 2008 |
| Modulation of pro-and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors F Facchetti, S Previdi, M Ballarini, S Minucci, P Perego, CAM La Porta Apoptosis 9 (5), 573-582, 2004 | 121 | 2004 |
| AQP1 is not only a water channel: it contributes to cell migration through Lin7/beta-catenin E Monzani, R Bazzotti, C Perego, CAM La Porta PLoS One 4 (7), e6167, 2009 | 100 | 2009 |
| Drug resistance in melanoma: new perspectives CAM La Porta Current medicinal chemistry 14 (4), 387-391, 2007 | 97 | 2007 |
| Increased plasma levels of soluble CD40, together with the decrease of TGFβ1, as possible differential markers of Alzheimer disease A Mocali, S Cedrola, N Della Malva, M Bontempelli, VAM Mitidieri, ... Experimental gerontology 39 (10), 1555-1561, 2004 | 77 | 2004 |
| Cancer stem cells and therapeutic perspectives E Galmozzi, F Facchetti, CAM Porta Current medicinal chemistry 13 (6), 603-607, 2006 | 64 | 2006 |
| Unique expression and localization of aquaporin‐4 and aquaporin‐9 in murine and human neural stem cells and in their glial progeny C Cavazzin, D Ferrari, F Facchetti, A Russignan, AL Vescovi, ... Glia 53 (2), 167-181, 2006 | 64 | 2006 |
| Mechanism of drug sensitivity and resistance in melanoma. CAP La Current cancer drug targets 9 (3), 391-397, 2009 | 61 | 2009 |
| CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells R Taghizadeh, M Noh, YH Huh, E Ciusani, L Sigalotti, M Maio, B Arosio, ... PloS one 5 (12), e15183, 2010 | 59 | 2010 |
| Cancer stem cells: lessons from melanoma C La Porta Stem Cell Reviews and Reports 5 (1), 61-65, 2009 | 55 | 2009 |
| Decrease of TGF-β1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease B De Servi, CAM La Porta, M Bontempelli, R Comolli Experimental gerontology 37 (6), 813-821, 2002 | 55 | 2002 |
| Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat … S Consolo, R Bertorelli, P Girotti, C La Porta, T Bartfai, M Parenti, ... Neuroscience letters 126 (1), 29-32, 1991 | 53 | 1991 |
| The water channels, new druggable targets to combat cancer cell survival, invasiveness and metastasis E Monzani, AA Shtil, CAM La Porta Current drug targets 8 (10), 1132-1137, 2007 | 50 | 2007 |
| Changes in protein kinase C alpha, delta and in nuclear beta isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat. CA La Porta, L Tessitore, R Comolli Carcinogenesis 18 (4), 715-719, 1997 | 50 | 1997 |
| Senescent cells in growing tumors: population dynamics and cancer stem cells CAM La Porta, S Zapperi, JP Sethna PLoS computational biology 8 (1), e1002316, 2012 | 47 | 2012 |
| Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers S Zapperi, CAM La Porta Scientific reports 2, 441, 2012 | 45 | 2012 |
| Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers S Zapperi, CAM La Porta Scientific reports 2, 441, 2012 | 45 | 2012 |
| Thoughts about cancer stem cells in solid tumors CAM La Porta World journal of stem cells 4 (3), 17, 2012 | 41 | 2012 |
